NASDAQ:MBOT • US59503A2042
The current stock price of MBOT is 2.45 USD. Today MBOT is up by 2.51%. In the past month the price increased by 36.11%. In the past year, price increased by 68.97%.
ChartMill assigns a technical rating of 7 / 10 to MBOT. When comparing the yearly performance of all stocks, MBOT is one of the better performing stocks in the market, outperforming 88.15% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to MBOT. No worries on liquidiy or solvency for MBOT as it has an excellent financial health rating, but there are worries on the profitability.
8 analysts have analysed MBOT and the average price target is 6.8 USD. This implies a price increase of 177.55% is expected in the next year compared to the current price of 2.45.
Over the last trailing twelve months MBOT reported a non-GAAP Earnings per Share(EPS) of -0.46. The EPS increased by 35.21% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -15.99% | ||
| ROE | -16.71% | ||
| Debt/Equity | 0 |
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.7 | 197.553B | ||
| ISRG | INTUITIVE SURGICAL INC | 49.03 | 176.649B | ||
| SYK | STRYKER CORP | 25.26 | 147.075B | ||
| BSX | BOSTON SCIENTIFIC CORP | 20.62 | 109.521B | ||
| IDXX | IDEXX LABORATORIES INC | 43.78 | 50.748B | ||
| BDX | BECTON DICKINSON AND CO | 10.88 | 49.634B | ||
| EW | EDWARDS LIFESCIENCES CORP | 28.66 | 49.488B | ||
| RMD | RESMED INC | 21.1 | 37.626B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.73 | 35.608B | ||
| DXCM | DEXCOM INC | 28.87 | 28.503B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.18 | 19.416B | ||
| PODD | INSULET CORP | 38.31 | 17.013B | ||
| HOLX | HOLOGIC INC | 15.04 | 16.846B |
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Microbot Medical, Inc. is a pre-clinical medical device company engaged in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The company is headquartered in Hingham, Massachusetts and currently employs 21 full-time employees. The company has developed the single-use, fully disposable endovascular robotic system, which aims to eliminate traditional barriers to accessing advanced robotic systems. The company specializes in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the body’s vasculature. The company eliminates the need for extensive capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. Its addressable markets for the LIBERTY Endovascular Robotic Surgical System include the peripheral interventional radiology, interventional cardiology and interventional neuroradiology markets.
MICROBOT MEDICAL INC
175 Derby St Bld 27
Hingham MASSACHUSETTS 02043 US
CEO: Harel Gadot
Employees: 21
Phone: 17818753605
Microbot Medical, Inc. is a pre-clinical medical device company engaged in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The company is headquartered in Hingham, Massachusetts and currently employs 21 full-time employees. The company has developed the single-use, fully disposable endovascular robotic system, which aims to eliminate traditional barriers to accessing advanced robotic systems. The company specializes in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the body’s vasculature. The company eliminates the need for extensive capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. Its addressable markets for the LIBERTY Endovascular Robotic Surgical System include the peripheral interventional radiology, interventional cardiology and interventional neuroradiology markets.
The current stock price of MBOT is 2.45 USD. The price increased by 2.51% in the last trading session.
MBOT does not pay a dividend.
MBOT has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
MICROBOT MEDICAL INC (MBOT) currently has 21 employees.
MICROBOT MEDICAL INC (MBOT) has a market capitalization of 164.54M USD. This makes MBOT a Micro Cap stock.
The outstanding short interest for MICROBOT MEDICAL INC (MBOT) is 10.96% of its float.